Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bruker Inks Share Purchase Agreement To Acquire Molecular Diagnostics Company ELITechGroup; Deal Value €870 M Cash, Excluding Carved Out ELITech Clinical Chemistry Business

Author: Benzinga Newsdesk | February 28, 2024 08:18am

As reported in an 8-K SEC filing on December 26, 2023, Bruker had previously entered into a put option agreement with the sellers, pending workers' council consultations in France and The Netherlands. Bruker expects to close the transaction in the second quarter of 2024. ELITechGroup, excluding the clinical chemistry business, achieved approximately €150 million in revenues in 2023.

Posted In: BRKR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist